Human Proteomics Program Overview

The Human Proteomics Program provides scientists at the University of Wisconsin-Madison with new opportunities for collaborative research as well as new tools for understanding and diagnosing human diseases. The Program features mass spectrometry as its primary technology due to its combination of general applicability, unprecedented sensitivity and high resolution analysis of proteins from biological tissues. The program has been made possible through grant funding from the Wisconsin Partnership for a Healthy Future.

The proteomics revolution is in full swing in the international biomedical research community as a way to study and ultimately identify the protein molecules that confer health and disease in humans. The Human Proteomics Program is dedicated to addressing the needs of researchers and clinicians at the UW School of Medicine and Public Health in the rapidly growing field of proteomics. The Program develops and administers core facilities in Mass Spectrometry and Bioinformatics as a means to facilitate fundamental understanding of disease states, discovery of biomarkers of disease and translation of these advances to improved clinical diagnostics and population screening in the state of Wisconsin. The Program works collaboratively with campus mass spectrometry facilities in the Biotechnology Center, Department of Chemistry, and School of Pharmacy to achieve synergies and accelerate progress toward these goals.

The Program is School-wide in scope but is administered through the Department of Cell and Regenerative Biology with instrument spaces in both the Wisconsin Institutes for Medical Research (WIMR) and in SMI 120-134 in the Medical Science Center (MSC).

Read More: Introduction to Disease Proteomics